Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzoyl Peroxide for Recurrent HSV-1
NCT07032649Phase 2Not yet recruiting
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of benzoyl peroxide in herpes labialis (2 arms). Primary endpoint: Time to First Recurrence of HSV-1 Outbreaks Within 6 Months. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
benzoyl peroxide
03
Conditions
herpes labialis
Beyond the preview
Go deeper on NCT07032649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07032649.